Skip to content
Dx

ICD-10-PCS 2027 procedure code

XW043G7Introduction of Allogeneic Engineered Chimeric Antigen Receptor T-cell Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 7

✓ Valid for 2027Non-O.R. procedure

Short description: Introduce Allogen CAR T in Central Vein, Perc, New Tech 7

Code last changed in FY2022 (effective October 1, 2021). Source: official FY2027 ICD-10-PCS release from CMS. Page updated September 29, 2026. About our data

About XW043G7

XW043G7 is the ICD-10-PCS code for a introduction procedure on the central vein using a percutaneous approach with engineered chimeric antigen receptor t-cell immunotherapy, allogeneic (qualifier: new technology group 7). In ICD-10-PCS, introduction means putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.

For a different body part, codes include XW033G7 (peripheral vein).

With a different device, use XW04357 (ifezuntirgene inilparvovec), XW043A7 (ciltacabtagene autoleucel), XW043C7 (recombinant human bone morphogenetic protein-2 with collagen scaffold), XW043H7 (paclitaxel-coated balloon technology, one balloon), XW043J7 (paclitaxel-coated balloon technology, two balloons), XW043K7 (paclitaxel-coated balloon technology, three balloons) and 3 more.

It is a non-O.R. procedure that is part of the MS-DRG logic for DRG 018 (Chimeric Antigen Receptor (CAR) T-Cell and Other Immunotherapies), under the surgical category “Chimeric Antigen Receptor (CAR) T-Cell and Other Immunotherapies”.

It was added in FY2022, effective October 1, 2021.

What each character means

1. Section
XNew Technology
2. Body System
WAnatomical Regions
3. Operation
0Introduction

Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products

4. Body Part
4Central Vein
5. Approach
3Percutaneous

Entry, by puncture or minor incision, of instrumentation through the skin or mucous membrane and any other body layers necessary to reach the site of the procedure

6. Device / Substance / Technology
GEngineered Chimeric Antigen Receptor T-cell Immunotherapy, Allogeneic
7. Qualifier
7New Technology Group 7

Other versions of this procedure

Different body part

MS-DRG v44.0 grouping

All DRGs →

Surgical MS-DRGs this procedure can group to, depending on the principal diagnosis's MDC.

MDC PRE · Pre-MDC · Chimeric Antigen Receptor (CAR) T-Cell and Other Immunotherapies

Code history

  1. 2016
  2. 2017
  3. 2018
  4. 2019
  5. 2020
  6. 2021
  7. 2022
  8. 2023
  9. 2024
  10. 2025
  11. 2026
  12. 2027
  • FY2022 (effective 10/1/2021): Added
  • No changes since FY2022.

Common questions about XW043G7

Is XW043G7 a valid ICD-10-PCS code for 2027?

Yes. XW043G7 is valid for inpatient procedures from October 1, 2026 through September 30, 2027.

Is XW043G7 an O.R. procedure?

No. XW043G7 is designated non-O.R. in MS-DRG v44.0.

What DRG does XW043G7 group to?

Depending on the principal diagnosis, XW043G7 can group to MS-DRG 018.